trending Market Intelligence /marketintelligence/en/news-insights/trending/VzejY9NrMD60wVxr9GHoUg2 content esgSubNav
In This List

Charles River Laboratories closes $500M senior notes offering

Blog

Insight Weekly: Private equity slows; SPAC underwriters retreat; carbon capture boost

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms


Charles River Laboratories closes $500M senior notes offering

Charles River Laboratories International Inc. closed an unregistered offering of $500 million of its 4.25% senior notes due 2028.

The Wilmington, Mass.-based research company plans to use the net proceeds from the offering as well as cash on hand to prepay a portion of its term loan facility and to pay related fees and expenses.

Charles River Laboratories is an early-stage contract research company that provides drug discovery, nonclinical development and safety-testing services worldwide.